Research Topics
Species | Robert J GlynnSummaryAffiliation: Brigham and Women's Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Indications for propensity scores and review of their use in pharmacoepidemiologyRobert J Glynn
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Basic Clin Pharmacol Toxicol 98:253-9. 2006..Use of propensity scores will not correct biases from unmeasured confounders, but can aid in understanding determinants of drug use and lead to improved estimates of drug effects in some settings...
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in preventionPaul M Ridker
Center for Cardiovascular Disease Prevention and the Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Circ Cardiovasc Qual Outcomes 2:616-23. 2009..However, whether the absolute risk reduction among such individuals justifies wide application of statin therapy in primary prevention is a controversial issue with broad policy and public health implications...
A randomized trial of rosuvastatin in the prevention of venous thromboembolismRobert J Glynn
Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
N Engl J Med 360:1851-61. 2009..Observational studies have yielded variable estimates of the effect of statin therapy on the risk of venous thromboembolism, and evidence from randomized trials is lacking...
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trialPaul M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Lancet 376:333-9. 2010..We addressed, using the JUPITER trial cohort, whether this association remains when LDL-cholesterol concentrations are reduced to the very low ranges with high-dose statin treatment...
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
N Engl J Med 359:2195-207. 2008....
Age-related cataract in a randomized trial of vitamins E and C in menWilliam G Christen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02215 1204, USA
Arch Ophthalmol 128:1397-405. 2010..To test whether supplementation with alternate-day vitamin E or daily vitamin C affects the incidence of age-related cataract in a large cohort of men...
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Med Care 45:S131-42. 2007..The goal of restricting study populations is to make patients more homogeneous regarding potential confounding factors and treatment effects and thereby achieve less biased effect estimates...
Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medicationsColin R Dormuth
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Clin Ther 30:1038-50. 2008..Objective: The aim of this study was to compare the effects of 2 recent cost-sharing policies on emergency hospitalizations due to chronic obstructive pulmonary disease, asthma, or emphysema (CAE), and on physician visits...
Beneficiaries with cardiovascular disease and thePart D coverage gapJennifer M Polinski
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
Circ Cardiovasc Qual Outcomes 5:387-95. 2012..The coverage gap remains the subject of Congressional debate; evidence regarding its impact on cardiovascular drug use and health outcomes is needed...
On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an inteSamia Mora
Center for Cardiovascular Disease Prevention, Divisions of Preventive and Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
J Am Coll Cardiol 59:1521-8. 2012....
Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physiciansWilliam G Christen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Ophthalmology 119:1642-9. 2012..To test whether supplementation with alternate-day vitamin E or daily vitamin C affects the incidence of the diagnosis of age-related macular degeneration (AMD) in a large-scale randomized trial of male physicians...
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trialJ Michael Gaziano
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
JAMA 301:52-62. 2009..No previous trial in men at usual risk has examined vitamin C alone in the prevention of cancer...
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trialPaul M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Lancet 373:1175-82. 2009..8 mmol/L (<70 mg/dL). However, the benefit of lowering both LDL cholesterol and hsCRP after the start of statin therapy is controversial. We prospectively tested this hypothesis...
Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St Ste 3030, Boston, MA 02120, USA
Am J Manag Care 13:445-52. 2007....
Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trialMichelle A Albert
Division of Cardiovascular Diseases, Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Am Heart J 162:106-14.e2. 2011..The aim of this study was to evaluate the effect of statin treatment in primary prevention of cardiovascular events in different race/ethnic groups...
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trialJ Michael Gaziano
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
JAMA 308:1871-80. 2012..Observational studies have not provided evidence regarding associations of multivitamin use with total and site-specific cancer incidence or mortality...
Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groupsDaniel H Solomon
Brigham and Women s Hospital, 1620 Tremont Street, Boston, MA 02120, USA
Arthritis Rheum 59:1097-104. 2008..There is substantial concern regarding the potential cardiovascular adverse effects of selective coxibs and nonselective NSAIDs, but many patients with arthritis experience important clinical benefits from these agents...
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapiesNiteesh K Choudhry
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
Am Heart J 156:31-6. 2008..Removing patient out-of-pocket drug costs may increase adherence, improve clinical outcomes, and even reduce overall health costs for high-risk patients. The existing data are inadequate to assess whether this strategy is effective...
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysisSoko Setoguchi
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
J Am Coll Cardiol 51:1247-54. 2008..We sought to assess the relationship between increasing use of cardiovascular medications and trends in long-term prognosis after myocardial infarction (MI) in the elderly...
Beta carotene supplementation and age-related maculopathy in a randomized trial of US physiciansWilliam G Christen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215 1204, USA
Arch Ophthalmol 125:333-9. 2007..To test whether beta carotene supplementation affects the incidence of age-related maculopathy (ARM) in a large-scale randomized trial...
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPSamia Mora
Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Circulation 121:1069-77. 2010..We analyzed sex-specific outcomes in the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and synthesized the results with prior trials...
Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in womenDavid Conen
Center for Arrhythmia Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
Circulation 119:2146-52. 2009..The influence of systolic and diastolic blood pressure (BP) on incident atrial fibrillation (AF) is not well studied among initially healthy, middle-aged women...
Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization dataSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Gigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
J Gen Intern Med 19:444-50. 2004..We sought to evaluate and rank the performance of comorbidity scores across selected U.S. and Canadian elderly populations using health care utilization databases...
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital recordsYuka Kiyota
Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, Mass USA
Am Heart J 148:99-104. 2004..1% vs 94.6%, P <.001). CONCLUSIONS: In this study, we observed high positive predictive values for a Medicare claims-based diagnosis of AMI and a diagnosis based on structured hospital record review...
Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort studyDavid Conen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, USA
J Hypertens 26:1780-6. 2008..The aim of the present study was to assess the relationship of six previously characterized gene variants in the renin-angiotensin system and the NOS3 gene with blood pressure progression and incident hypertension...
The comparative safety of opioids for nonmalignant pain in older adultsDaniel H Solomon
Division of Pharmacoepidemiology, Brigham and Women s Hospital, Boston, MA 02115, USA
Arch Intern Med 170:1979-86. 2010..However, there is relatively little information about the comparative safety of opioids. Therefore, we sought to compare the safety of opioids commonly used for nonmalignant pain...
Evaluation of risk factors for cataract types in a competing risks frameworkRobert J Glynn
Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
Ophthalmic Epidemiol 16:98-106. 2009..One can compare the impact of risk factors on different types of cataract with methods of competing risk survival analysis that account for tied events...
Risk factors for mortality in the nurses' health study: a competing risks analysisHeather J Baer
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Am J Epidemiol 173:319-29. 2011..In the future, this new model may be used to identify individuals at increased risk of mortality...
Instrumental variable analysis for estimation of treatment effects with dichotomous outcomesJeremy A Rassen
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
Am J Epidemiol 169:273-84. 2009..Generalized method of moments estimation produced substantially the same results as the 2-stage logistic method. Few substantive differences among the methods were observed, despite their reliance on distinct assumptions...
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trialHoward D Sesso
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA
JAMA 300:2123-33. 2008..However, few long-term trials have evaluated men at initially low risk of cardiovascular disease, and no previous trial in men has examined vitamin C alone in the prevention of cardiovascular disease...
Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medicationsColin R Dormuth
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Med Care 47:508-16. 2009..We analyzed the impact on health plan spending of a switch in public drug insurance from full coverage to a prescription copayment (copay), and then to income-based deductibles plus coinsurance (IBD)...
Excess weight and the risk of incident coronary heart disease among men and womenAlan J Flint
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
Obesity (Silver Spring) 18:377-83. 2010..A substantial proportion of incident CHD may be attributed to excess weight...
The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adultsAmanda R Patrick
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Value Health 14:513-20. 2011....
Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health StudyTimothy C Lee
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
PLoS ONE 6:e27670. 2011..We prospectively examined whether socioeconomic status (SES) predicts incident type II diabetes (diabetes), a cardiovascular risk equivalent and burgeoning public health epidemic among women...
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular StudyWilliam G Christen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 900 Commonwealth Avenue E, Boston, MA 02215 1204, USA
Arch Intern Med 169:335-41. 2009..Our objective was to examine the incidence of AMD in a trial of combined folic acid, pyridoxine hydrochloride (vitamin B(6)), and cyanocobalamin (vitamin B(12)) therapy...
Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER StudyRobert J Glynn
Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Clin Chem 55:305-12. 2009..Although studies of specific populations have suggested that hsCRP is a reliable longitudinal marker, it is unclear how strongly hsCRP tracks in individuals after a single increased concentration...
Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionalsDavid Conen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Eur Heart J 30:1378-84. 2009..The aim of this study was to examine the association between socioeconomic status, blood pressure (BP) progression, and incident hypertension...
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthmaColin R Dormuth
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Clin Ther 28:964-78; discussion 962-3. 2006..Evaluations of drug cost-sharing policies within the same population are needed for a fair comparison of different options...
Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trialRobert J Glynn
Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
Ann Intern Med 152:488-96, W174. 2010..Randomized data on statins for primary prevention in older persons are limited, and the relative hazard of cardiovascular disease associated with an elevated cholesterol level weakens with advancing age...
Full coverage for preventive medications after myocardial infarctionNiteesh K Choudhry
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
N Engl J Med 365:2088-97. 2011..Adherence to medications that are prescribed after myocardial infarction is poor. Eliminating out-of-pocket costs may increase adherence and improve outcomes...
Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of womenWilliam G Christen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
Ophthalmology 116:2386-92. 2009..To test whether alternate-day low-dose aspirin affects incidence of age-related macular degeneration (AMD) in a large-scale randomized trial of women...
Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensivesPhilip S Wang
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Hypertension 46:273-9. 2005..Highly prevalent, noncardiovascular conditions appear to deter use of antihypertensives in elderly with hypertension...
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external informationTIL STURMER
Divisions of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Med Care 45:S158-65. 2007..Nonexperimental studies of drug effects in large automated databases can provide timely assessment of real-life drug use, but are prone to confounding by variables that are not contained in these databases and thus cannot be controlled...
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experimentSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
Circulation 115:2128-35. 2007....
The comparative safety of analgesics in older adults with arthritisDaniel H Solomon
Division of Pharmacoepidemiology, Brigham and Women s Hospital, Boston, MA 02115, USA
Arch Intern Med 170:1968-76. 2010..The safety of alternative analgesics is unclear. We examined the comparative safety of nonselective NSAIDs (nsNSAIDs), selective cyclooxygenase 2 inhibitors (coxibs), and opioids...
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating RosuvasPaul M Ridker
Center for Cardiovascular Disease Prevention and Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Circ Cardiovasc Qual Outcomes 3:447-52. 2010..However, trial data directly addressing whether this recommendation defines a patient population in which statin therapy is effective have not previously been published...
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trialHoward D Sesso
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02215, USA
JAMA 308:1751-60. 2012..Observational studies have shown inconsistent associations between regular multivitamin use and CVD, with no long-term clinical trials of multivitamin use...
Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in womenWilliam G Christen
Divisions of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Arch Ophthalmol 129:921-9. 2011..To examine whether intake of ω-3 fatty acids and fish affects incidence of age-related macular degeneration (AMD) in women...
NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxibSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Boston, MA 021205, USA
Pharmacoepidemiol Drug Saf 18:1134-42. 2009....
Vitamin E and age-related macular degeneration in a randomized trial of womenWilliam G Christen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
Ophthalmology 117:1163-8. 2010..To test whether alternate day vitamin E affects the incidence of age-related macular degeneration (AMD) in a large-scale randomized trial of women...
High-dimensional propensity score adjustment in studies of treatment effects using health care claims dataSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Epidemiology 20:512-22. 2009..Here, we develop and test an algorithm that empirically identifies candidate covariates, prioritizes covariates, and integrates them into a propensity-score-based confounder adjustment model...
Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry dataSoko Setoguchi
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
Cancer Causes Control 18:561-9. 2007..However, linkage between cancer registry and claims data including pharmacy-dispensing information is not always available. We examined the accuracy of claims-based definitions of incident cancers and their date of diagnosis...
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarctionSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
Epidemiology 16:17-24. 2005..We show how to assess the impact of confounding by factors not measured in Medicare claims data in a study of the association between selective COX2 inhibitors and acute myocardial infarction (MI)...
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trialJulie Lin
Renal Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Diabetes Care 31:2338-43. 2008..Early albuminuria probably reflects vascular endothelial dysfunction, which may be mediated in part by chronic inflammation...
Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolismRobert J Glynn
Division of Preventive Medicine and the Channing Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Am J Epidemiol 162:975-82. 2005..CHD and stroke have broadly comparable risk factor profiles that differ widely from the profile for VTE...
Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort studyDavid Conen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA
BMJ 335:432. 2007..To compare cardiovascular risk among women with high normal blood pressure (130-9/85-9 mm Hg) against those with normal blood pressure (120-9/75-84 mm Hg) and those with baseline hypertension...
Assessing health state utilities in elderly patients at cardiovascular riskWolfgang C Winkelmayer
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
Med Decis Making 26:247-54. 2006..Health state preferences can be a crucial component of cost-effectiveness analyses, but off-the-shelf health state utilities specifically for older people are not available...
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)Paul M Ridker
Center for Cardiovascular Disease Prevention, Boston, Massachusetts, USA
Am J Cardiol 106:204-9. 2010..In conclusion, as the absolute risk increased with increasing hs-CRP, the absolute risk reduction associated with rosuvastatin within JUPITER was also greatest among those with the greatest entry hs-CRP levels...
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation studyTIL STURMER
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Am J Epidemiol 172:843-54. 2010..Increasing validity based on PS trimming may be a unique advantage of PS's over conventional outcome models...
Colorectal cancer after start of nonsteroidal anti-inflammatory drug useTIL STURMER
Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02215, USA
Am J Med 119:494-502. 2006....
A combined comorbidity score predicted mortality in elderly patients better than existing scoresJoshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
J Clin Epidemiol 64:749-59. 2011..To develop and validate a single numerical comorbidity score for predicting short- and long-term mortality, by combining conditions in the Charlson and Elixhauser measures...
Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approachRobert Y L Zee
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Clin Chim Acta 402:189-92. 2009....
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in womenDebra A Schaumberg
Division of Preventive Medicine, 900 Commonwealth Ave E, Boston, MA 02215, USA
Arch Ophthalmol 125:300-5. 2007..To investigate whether high-sensitivity C-reactive protein (hsCRP) and other biomarkers of inflammation predict age-related macular degeneration (AMD)...
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Paul M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
J Am Coll Cardiol 55:1266-73. 2010..We evaluated the efficacy of statin therapy in primary prevention among individuals with moderate chronic kidney disease (CKD)...
Design of cluster-randomized trials of quality improvement interventions aimed at medical care providersRobert J Glynn
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
Med Care 45:S38-43. 2007..Such trials are frequently embedded in health care systems with available automated records, which can be used to enhance the design of the trial...
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trialBrendan M Everett
The Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
Clin Ther 30:661-72. 2008....
Evaluating uses of data mining techniques in propensity score estimation: a simulation studySoko Setoguchi
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02130, USA
Pharmacoepidemiol Drug Saf 17:546-55. 2008....
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trialRobert J Glynn
Brigham and Women s Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts 02215, USA
Ann Intern Med 147:525-33. 2007..Short-term aspirin therapy can lower the risk for venous thromboembolism (VTE) in high-risk patients, but whether the long-term use of low-dose aspirin reduces risk in healthy adults is uncertain...
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methodsTIL STURMER
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
J Clin Epidemiol 59:437-47. 2006..Such analyses have been proposed to address confounding by indication, but there is little empirical evidence that they achieve better control than conventional multivariate outcome modeling...
Extension of the rank sum test for clustered data: two-group comparisons with group membership defined at the subunit levelBernard Rosner
Channing Laboratory, Harvard Medical School, Boston, Massachusetts 02115, USA
Biometrics 62:1251-9. 2006..We also present comparisons between the clustered Wilcoxon test and each of the signed rank tests and mixed model approaches and show dramatic differences in power in favor of the clustered Wilcoxon test for some designs...
Insights into different results from different causal contrasts in the presence of effect-measure modificationTIL STURMER
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
Pharmacoepidemiol Drug Saf 15:698-709. 2006..In the presence of effect-measure modification, different analytic approaches produce different summary estimates...
A nonparametric test for observational non-normally distributed ophthalmic data with eye-specific exposures and outcomesBernard Rosner
Channing Laboratory, Harvard Medical School, Boston, Massachusetts 02115, USA
Ophthalmic Epidemiol 14:243-50. 2007....
Methods to evaluate risks for composite end points and their individual componentsRobert J Glynn
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Harvard School of Public Health, 900 Commonwealth Avenue East, Boston, MA 02215 1204, USA
J Clin Epidemiol 57:113-22. 2004..Both randomized and observational studies commonly examine composite end points, but the literature on model development and criticism in this setting is limited...
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockersSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02120, USA
Clin Pharmacol Ther 74:388-400. 2003....
Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approachBernard Rosner
Channing Laboratory, Harvard Medical School, 181 Longwood Avenue, Boston, Massachusetts, USA
Biometrics 59:1089-98. 2003..In this article, we present large-sample theory and simulation results for this test procedure and apply it to diabetic retinopathy data from type I diabetics in the Sorbinil Retinopathy Trial...
Improved comorbidity adjustment for predicting mortality in Medicare populationsSebastian Schneeweiss
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Health Serv Res 38:1103-20. 2003..80. CONCLUSIONS: We conclude that in epidemiologic studies of the elderly, a modified diagnosis-based score using empirically derived weights provides improved adjustment for comorbidity and enhances the validity of findings...
Stopping rules for surveys with multiple waves of nonrespondent follow-upR Sowmya Rao
MGH Biostatistics Center and the Institute for Health Policy, Harvard Medical School, 50 Staniford Street, Suite 560, Boston, MA 02114, U S A
Stat Med 27:2196-213. 2008..The rules are not complicated and may be applied in a straightforward manner. Discontinuing follow-up would save time and possibly resources, and adjusting for the nonresponse in the analysis would reduce the impact of nonresponse bias...
Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factorsM Alan Brookhart
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
J Clin Epidemiol 59:18-25. 2006..A statistical method is presented for attributing explained variation in patient care to different levels of aggregation in a multilevel model with the aim of prioritizing and targeting quality improvement interventions...
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effectTobias Kurth
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Am J Epidemiol 163:262-70. 2006..Researchers need to be clear about the population for which an overall treatment estimate is most suitable...
Interval estimation for rank correlation coefficients based on the probit transformation with extension to measurement error correction of correlated ranked dataBernard Rosner
Channing Laboratory, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
Stat Med 26:633-46. 2007..This extends previous work by Rosner and Willett for obtaining point and interval estimates of measurement error corrected Pearson correlations...
Variable selection for propensity score modelsM Alan Brookhart
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
Am J Epidemiol 163:1149-56. 2006..These simulation studies and other analytical results suggest that standard model-building tools designed to create good predictive models of the exposure will not always lead to optimal PS models, particularly in small studies...
Multiple imputation to estimate the association between eyes in disease progression with interval-censored dataRobert J Glynn
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, USA
Stat Med 23:3307-18. 2004..A simulation study suggests that the method performs well. Results highlight the advantage of multiple imputation that data imputed under one model can be analysed under several alternative models...
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolismPaul M Ridker
N Engl J Med 349:2164-7; author reply 2164-7. 2003
Aspirin and nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: weighing the evidenceTIL STURMER
Ann Intern Med 147:674; author reply 674-5. 2007
